APA (7th ed.) Citation

Walunj, D., Egarmina, K., Zipin-Roitman, A., Muddineni, S. S. N. A., Tkachenko, I., Mitra, P., . . . Gellerman, G. (2025). Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-94373-8

Chicago Style (17th ed.) Citation

Walunj, Dipak, et al. "Novel Dual Action Chimera Doxorubizen Demonstrates Superior Efficacy to Doxorubicin in Acute Leukemia." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-94373-8.

MLA (9th ed.) Citation

Walunj, Dipak, et al. "Novel Dual Action Chimera Doxorubizen Demonstrates Superior Efficacy to Doxorubicin in Acute Leukemia." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-94373-8.